---
schema_version: "secwatch.filing_event.v1"
accession: "0001299130-26-000092"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2026-06-04T21:19:08+00:00"
generated_at: "2026-06-04T21:21:37.582702+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve 16M share increase in equity plan at Pacific Biosciences annual meeting

## Summary
- Stockholders approved amendment to 2020 Equity Incentive Plan, adding 16,000,000 shares for future grants.
- Four Class III directors elected: Ericson, Ordoñez, Smith, Gibson, Henry, Milligan.
- Ernst & Young ratified as independent registered public accounting firm for FY2026.
- Advisory say-on-pay proposal approved with 114,050,930 votes for, 21,239,989 against.
- Annual meeting had ~65% of shares represented (203,009,375 of 310,487,099 outstanding).

## SEC filing metadata
- accession: 0001299130-26-000092
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2026-06-04T21:19:08+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/pacb-20260603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001299130-26-000092
- JSON: https://secwatch.observer/filing/0001299130-26-000092.json
- Plain text: https://secwatch.observer/filing/0001299130-26-000092.txt

## Key facts
- Shareholder Votes
  PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Election of Four Class III Directors at the 2026-06-03 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-03
  source text: Proposal 1: Election of Four Class III Directors Name of Director For Against Abstain Broker Non-Votes William Ericson 128,010,323 8,109,601 1,111,140 65,778,311 Kathy Ordoñez 130,522,400 5,673,816 1,034,848 65,778,311 Christopher M. Smith 131,731,235 4,069,337 1,430,492 65,778,311 Chris Gibson, Ph.D. 131,899,750 4,107,270 1,224,044 65,778,311 Christian O. Henry 129,999,918 5,924,115 1,307,031 65,778,311 John F. Milligan, Ph.D. 130,471,635 5,650,906 1,108,523 65,778,311 Each director nominee was duly elected
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm
- Shareholder Votes
  PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-03 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-03
  source text: Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 198,046,666 3,990,483 972,226 — The stockholders ratified the appointment of Ernst & Young LLP
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm
- Shareholder Votes
  PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Advisory Vote on Approval of Named Executive Officer Compensation at the 2026-06-03 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-03
  source text: Proposal 3: Advisory Vote on Approval of Named Executive Officer Compensation For Against Abstain Broker Non-Votes 114,050,930 21,239,989 1,940,145 65,778,311 The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm
- Shareholder Votes
  PACIFIC BIOSCIENCES OF CALIFORNIA, INC. shareholders approved Approval of Amendment to the 2020 Equity Incentive Plan at the 2026-06-03 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-03
  source text: Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan For Against Abstain Broker Non-Votes 114,865,820 20,469,132 1,896,112 65,778,311 The stockholders approved the amendment to the 2020 Plan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000129913026000092/0001299130-26-000092-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.